Immunovant reported raising $450 Million in an initial SEC Form D filing, from an offering of $450 Million
Round Type
Venture
DurhamHealthcareHealth CareInvestors
Quick answer
Immunovant raised $450 Million in a funding round, dated January 15, 2025. Investors: Chief Immunovant and Roivant. Immunovant is based in Durham, North Carolina, United States.
- How much did Immunovant raise?
- Immunovant raised $450 Million in a funding round on January 15, 2025.
- Who invested in Immunovant?
- Chief Immunovant and Roivant are named as investors in this round.
- What does Immunovant do?
- Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases.
- Where is Immunovant based and how big is it?
- Immunovant is based in Durham, North Carolina, United States. Fundz records about 363 employees.
- Who are the decision-makers at Immunovant?
- Fundz holds 1 contact at Immunovant. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Immunovant that raised within 45 days of this round, from Fundz verified event records.
- Hummingbird Healthcare raised $20M (Series B) on February 21, 2025.
- Hummingbird Healthcare raised $19M on February 14, 2025.
- Brijjit Medical raised $5.6M (Seed) on February 28, 2025.
- Foresee Medical raised $950K (Seed) on February 27, 2025.
- SciSparc Ltd raised $4.2M (Seed) on February 25, 2025.
- MiRTLE Medical raised $405K (Seed) on February 25, 2025.
Who to call at Immunovant, and when
A new round usually means Immunovant is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Immunovant raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Immunovant, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Immunovant. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Immunovant raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Immunovant raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.